Patient care

...

Care at the Leukemia Institute

Care at the Leukemia Institute

The Leukemia Institute is here to support you at every stage of your care journey.
Specializing in the management of acute leukemias and related disorders, our institute brings together a dedicated team of professionals committed to providing you with cutting-edge care and innovative treatments tailored to your individual needs. We also offer psychological support for you and your loved ones.

Our ten clinical departments provide comprehensive care for patients of all ages, from children to seniors.

The Leukemia Institute in figures

1st

Leukemia Treatment and Research Center

16

Research Teams

10

Clinical Departments

4

Clinical Laboratories

Clinical departments

Department of senior hematology, Lionel Adès

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Outpatient Hemato-oncogenetics Unit, Marie Sébert

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Adolescent and Young Adult Unit, Nicolas Boissel

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Department of clinical hematology and cell therapy, Thorsten Braun

Avicenne Université Sorbonne Paris Nord Hospital

125 Route de Stalingrad 93000 Bobigny

Department of Pharmacology and Clinical Investigations, Vincent Lévy

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Hematology Transplant Unit , Régis Peffault de Latour

Saint-Louis Hospital

1 avenue Claude Vellefaux, 75010 Paris

Department of adult hematology, Emmanuel Raffoux

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Department of clinical haematology

Cochin–Port Royal Hospital

27 rue du Faubourg Saint Jacques – 75014 Paris

Department of Paediatric Hematology and Immunology, Jean-Hugues Dalle

Robert-Debré Hospital

48 boulevard Sérurier 75019 Paris

Multidisciplinary Team Meetings

Twice a month — on the first and third Wednesdays — national multidisciplinary team meetings (MDTs) are held via videoconference, bringing together two adult clinical specialists, two to three pediatric clinicians, and at least one expert hematology biologist.

Participants include clinical and laboratory hematologists, pediatricians, geneticists, genetic counselors, psychologists, and advanced practice nurses — occasionally joined by oncologists.

The cases discussed may involve:

  • Discussions on genetic testing indications for a patient or family (using dedicated gene panels or within the framework of a pre-indication under the French Genomic Medicine Plan).

  • Reviews to determine the pathogenicity of identified genetic variants.

  • Discussions to establish follow-up and prevention recommendations for patients and relatives carrying a genetic predisposition.

These multidisciplinary team meetings (MDTs), held via videoconference and on-demand, are open to external participants and bring together hematologists, obstetricians, pharmacologists, and anesthesiologists to discuss the management of patients diagnosed with malignant hematologic disorders during pregnancy.

These meetings bring together specialists in acute leukemia and allogeneic transplantation, as well as the transplantation coordination team, to optimize the transplantation plan. Discussions cover the transplant indication, scheduling (transplant date), donor type, and pre-transplant treatment protocols.

 

National bi-monthly videoconference meetings bring together adult and pediatric clinicians, hematology biologists, and geneticists to discuss cases of patients with acquired or congenital aplastic anemia and paroxysmal nocturnal hemoglobinuria for whom the reference center is consulted regarding therapeutic management. A written opinion is provided to the requesting physician.

Host foundation and founding members